Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Ipilimumab × 90 days × Clear all

Sponsor

Conditions

Melanoma 27 Carcinoma, Renal Cell 16 Carcinoma, Non-Small-Cell Lung 15 Neoplasm Metastasis 9 Skin Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Lung Neoplasms 5 Kidney Neoplasms 5 Carcinoma, Hepatocellular 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Merkel Cell 4 Urogenital Neoplasms 3 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Penile Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma, Malignant 3 Glioblastoma 3 Uveal Melanoma 2 Ureteral Neoplasms 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroendocrine Tumors 2 Myelodysplastic Syndromes 2

Interventions

pembrolizumab 2 Specimen Handling 2 Radiotherapy 2 Radiation 2 Doxorubicin 2 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 futibatinib 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Erlotinib Hydrochloride 1 Dactinomycin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡